Edward H Liao

Title: Edward H. Liao: Innovator in Chimeric Antigen Receptor Technology

Introduction

Edward H. Liao is a prominent inventor based in Petaluma, California. He is known for his significant contributions to the field of immunotherapy, particularly through his work on chimeric antigen receptors (CARs). His innovative approach has the potential to revolutionize cancer treatment.

Latest Patents

Edward H. Liao holds a patent for a chimeric antigen receptor that includes an NGK2D ecto domain. This patent encompasses compositions, cells, and cell therapies that utilize these CARs, along with methods of treatment. His work in this area is crucial for advancing therapeutic options for patients.

Career Highlights

Liao is currently employed at Kite Pharma, Inc., a leading biotechnology company focused on developing innovative cancer therapies. His role at Kite Pharma allows him to work at the forefront of CAR technology, contributing to groundbreaking advancements in the field.

Collaborations

Throughout his career, Edward has collaborated with notable colleagues, including Kevin P. Meng and Jodi Murakami. These partnerships have fostered a collaborative environment that enhances the development of innovative therapies.

Conclusion

Edward H. Liao's work in chimeric antigen receptor technology exemplifies the impact of innovation in the medical field. His contributions are paving the way for new treatment methodologies that could significantly improve patient outcomes.